San Francisco, United States
BioTrillion, a company founded in 2018 and headquartered in the United States, is at the forefront of transforming health monitoring through advanced technology. Their vision, as captured in their slogan, "Data from Life. Data for Life.", emphasizes their commitment to democratizing access to health insights.
Their innovative product, HealthySelfie™, utilizes smartphone cameras and cutting-edge AI and computer vision to deliver medical-grade diagnostics from a simple 10-second face scan. By transforming the smartphone into a diagnostic tool, BioTrillion addresses multiple sectors including telehealth, decentralized clinical trials, and insurance risk management.
The company's proprietary DiseaseSignatures™ technology analyzes biomarkers for early disease detection, validated against clinical standards and supported by globally pending patents. This positions BioTrillion as a key player in AI and digital health industries.
Their last funding, a $2.30M Seed Round in August 2018, secured support from investors such as David B. Kirk, Santosh Kumar, and Tom X Lee, along with firms like SVTC and Constellar Ventures, underscoring the potential scale and impact of BioTrillion's technology.
